STRATA Skin Sciences, Inc. (SSKN) Stock

STRATA Skin Sciences, Inc. is a leading medical technology company specializing in the development, commercialization, and global distribution of innovative products for the treatment of dermatologic conditions. Operating across multiple continents including the United States, Europe, Asia, Australia, and beyond, the company focuses on two primary segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its portfolio includes advanced technologies such as the XTRAC and Pharos excimer lasers, VTRAC lamp systems, and TheraClear treatment systems, which are pivotal in addressing conditions like psoriasis, vitiligo, acne, and other skin disorders.

The company's international presence is strengthened through strategic partnerships with distributors while maintaining a direct sales approach domestically, serving healthcare professionals directly. This enables STRATA Skin Sciences to efficiently deliver cutting-edge dermatologic solutions to physicians and their patients worldwide. Originally founded as MELA Sciences, Inc., the company underwent a rebranding in January 2016, adopting its current name to better reflect its expanded focus and commitment to advancing skin care through innovative medical technologies.

Established in 1989 and headquartered in Horsham, Pennsylvania, STRATA Skin Sciences continues to drive innovation in dermatology. With a strong foundation in research and development, coupled with a robust global distribution network, the company remains dedicated to improving outcomes for individuals affected by dermatologic conditions by providing effective, state-of-the-art treatment solutions.